Mechanism of action of electroconvulsive therapy in depression;Mecanismo de acción de la terapia electroconvulsiva en la depresión

Actas Espanolas de Psiquiatria

Volumn 29, Issue 3, 2001, Pages 199-207

  Rios B ^a   Vicente, N ^b  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b NONE

Author keywords

Electroconvulsive treatment; Mechanism of action; Neurobiological basis

Indexed keywords

AGNOSIA; ARTICLE; COGNITIVE DEFECT; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; PSYCHOLOGICAL THEORY;

AGNOSIA; COGNITION DISORDERS; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; PSYCHOLOGICAL THEORY;

EID: 17444433231     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Mann JJ, Mahler JC, Wilner PJ, Halper JP, Brown RP, Johnson KS, et al. Normalization of blunted lymphocite beta-adrenergic responsivity in melancholic impatients by a course of electroconvulsive therapy. Arch Gen Psychiatry 1990;47:461-4.
2. Newman ME, Lerer B. Chronic electroconvulsive shock and desipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes. Eur J Pharmacol 1988;148:257-60.
3. Swartz CM. Electroconvulsive Therapy Prolactin release as an Epiphenomenon. Convuls Ther 1991;7:85-91.
4. Potter WZ, Fink M. How does ECT work? Psychopharmacol Bull 1988;24:385-6.
5. West ED. Electric convulsion therapy in depression: A double-blind controlled trial. Br Med J Clin Res 1981;282:355-7.
6. Abse W. theory of the rationale of convulsive therapy. Br J Med Psychol 1944;20:33-50.
7. Schilder P. Notes o the psychology of metrazol treatment in schizophrenia. J Nerv Ment Dis 1939;89: 133-44.
8. Freeman CP, Kendell RE. ECT: I. Patients' experiences and attitudes. Br J Psychiatry 1980;137:8-16.
9. Weinstein EA, Linn L, Kahn RL. Psychosis during electroshock therapy: Its relation to the theory of shock therapy. Am J Psychiatry 1952;109:22-6.
10. Cutting J. Study of anosognosia. J Neurol Neurosurg Psychiatry 1978;41:548-55.
11. Sayer NA, Sackeim HA, Moeller JR, Prudic J, Devanand DP, Coleman E, Kiersky JE. The relations between observer-rating and self-report of depressive symptomatology. Psychol Assess 1993;5:350-60.
12. Summers WK, Robins E, Reich T. The natural history of acute organic mental syndrome after bilateral electroconvulsive therapy. Biol Psychiatry 1979;14: 905-12.
13. Miller ME, Siris SG, Gabriel AN. Treatment delays in the course of electroconvulsive therapy. Hosp Community Psychiatry 1986;37:825-7.
14. Breggin PR. Electroshock. Its Brain-Disabling Effects. New York: Springer; 1979.
15. Devanand DP, Sackeim HA. Seizure elicitation blocked by pre-treatment of mania and organic euphoria during ECT. J Clin Psychiatry 1988;49:69-71.
16. Sackeim HA. The cognitive effects of electroconvulsive therapy. En: Moos WH, Gamzu ER, Thai LJ, eds. Cognitive disorders: Pathophysiology and Treatment. New York: Marcel Dekker; 1992. p. 183-228.
17. Janis IL. Psychologic effects of electric convulsive treatments (III. Changes in affective disturbances) J Nerv Ment Dis 1950;III:469-89.
18. Cameron DE. Production of differential amnesia as a factor in the treatment of schizophrenia. Compr Psychiatry 1960;1:26-34.
19. Ottonsson JO. Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatr Scand 1960;145(Supl):1-141.
20. Sackeim HA, Decina P, Prohovnick I, et al. Anticonvulsivant and antidepressant properties of ECT: a proposed mechanism of action. Biol Psychiatry 1983;18:1301-10.
21. Post RM, Putnam F, Uhde TW, Weiss SR. Electroconvulsive therapy as an anticonvulsant. Implications for its mechanism of action in affective illness. Ann N Y Acad Sci 1986;462:376-88.
22. Sackeim HA, Mukherjee S. Neurophysiological variability in the effects of the ECT stimulus. Convuls Ther 1986;2:267-76.
23. Caplan G. Electrical convulsion therapy in treatment of epilepsy. J Ment Sci 1946;92:784-93.
24. Sackeim HA. Emotion, disorders of mood, and hemispheric specialization. En: Carroll BJ, Barrett JE, eds. Psychopathology and the Brain. New York: Raven Press; 1991 p. 209-42.
25. Sackeim HA. Physical properties and quantification of the ECT stimulus: Response to the commentaries. Convulsive Ther 1994;10:140-52.
26. Devanand DP, Shapira B, Petty F, Kramer G, Fitasimons L, Lerer B, Sackeim MA. Effects of electroconvulsive therapy on plasma GABA. Convuls Ther 1995;11:3-13.
27. Isaac L, Swanger, J. Alteration of electroconvulsive threshold by cerebrospinal fluid from cats tolerant to electroconvulsive shock. Life Sci 1983;33:2301-4.
28. Holaday JW, Tortella FC, Meyerhoff JL, Belenky GL, Hitzemann RJ. Electroconvulsive shock activates endogenous opioid systems: Behavioral and biochemical correlates. Ann N Y Acad Sci 1986;467:249.55.
29. Tortella FC, Long JB. Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid. Brain Res 1988;456:139-46.
30. Nobler MS, Sackeim HA, Prohovnik I, Moeller JR, Mukherjee S, Schnur DB, et al. Regional cerebral blood flow in mood disorders: III. Effects of treatment and clinical response in depression and mania. Arch Gen Psychiatry 1994;51:884-97.
31. Öhman R, Walinder J, Balldin J, Wallin L. Prolactin response to electroconvulsive therapy. Lancet 1976; 2:936-7.
32. Linnoila M, Miller TL, Bartko J, et al. Five antidepressant treatments in depressed patients. Effect on urinary 5-HT and 5-hidroxyindoleacetic acid output. Arch Gen Psychiatry 1984;41:688-92.
33. Balldin J, Granerus AK, Lindstedt G, Modigh K, Walinder J. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Psychopharmacology 1982;76:371-6.
34. Zis AP, Yatham LN, Lam RW, Clark CM, Srisurapanont M, McGarvey K. Effect of stimulus intensity on prolactin and cortisol realese induced by unilateral electroconvulsive therapy. Neuropsychopharmacology 1996;15:263-70.
35. Papakostas JG, Stefanis CS, Markianos M, Papadimitrious GM. Naloxone fails to block ECT induced prolactina increase. Biol Psychiatry 1985;20:1326-7.
36. Zis A, McGregory KA, Clark CM. The role of dopamine in seiszure induced prolactin release in humans. Convuls Ther 1992;8:126-30.
37. Papakostas J, Markianos M, Stefanis C. Methysergid reduces the prolactin response to ECT. Biol Psychiatry 1988;24:465-8.
38. Whalley LJ, Eagles JM, Bowler GM, Bennie JG, Dick HR, McGuire RJ, Fink M. Selective effects of ECT on hipothalamic pituitary activity. Psychol Med 1987; 17:319-28.
39. Decina P, Sackeim HA, Kahn DA, Pierson D, Hopkins N, Malitz S. Effects of ECT on the TRH stimulation test. Psychoneuroendocrinology 1987;12:29-34.
40. Kierkegard C, Moller SE, Bjonum N. Addition of L-trytophan on electroconvulsive treatment in endogenous depression: a double blind study. Acta Psychiatr Scand 1978;58:457-62.
41. Coppen A, Rama-Rao VA, Bishop M, Abou-Saleh MT, Wood K. Neuroendocrine studies in affective disorders: plasma prolactin response to TRH in affective disorders: effect of ECT. J Affect Dis 1980;2:311-5.
42. Scott AIF, Milner JB, Schering PA. Diminished TSH release after a course of ECT: altered monoamine function or seizure activity? Psychoneuroendocrinology 1989;14:425-31.
43. Brady LS, Lynn Ab, Glowa Jr, Le DQ, Herkenham M. Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin - releasin hormone and tyrosine hydroxilaes in rat brain. J Clin Invest 1994;94:1263-8.
44. Lykouras L, Markianos M, Hatzimanolis J, Stefanis C. Effects of ECT course on TSH and prolactin responses to TRH in depressed patients. J Affective Disord 1991;23:191-7.
45. Lykouras L, Markianos M, Augoustides A, Papakostas Y, Stefanis C. Evaluation of TSH and prolactin responses to TRH as predictors of the therapeutic effect of ECT in depression. Eur Neuropsychopharmacol 1993;3:81-3.
46. Stern RA, Nevels CT, Shelhorse ME, Prohaska ML, Mason GA, Prange AJ. Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings. Biol Psychiatry 1991;30:625-7.
47. Devanand DP, Decina P, Sackeim HA, Hopkins N, Novacenko H, Malitz S. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy. Biol Psychiatry 1987;22:463-72.
48. Devanand DP, Sackeim HA, Lo ES, Cooper T, Huttinot G, Prudic J. Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression. Arch Gen Psychiatry 1991;48:525-33.
49. Whalley LJ, Rosic R, Dick H, Levy G, Watts AG, Sheward WJ, et al. Inmediate increases inplasma prolactin and neurphysin, bur not other hormones after electroconvulsive therapy. Lancet 1982;2:1064-8.
50. Scott AIF, Milner JB, Schering PA, Beckett GJ. Fall in free thyroxine after ECT: Real effect or an artefact of assay? Biol Psychiatry 1990;27:784-6.
51. Devanand DP, Lisanby S, Lo ES, Fitzsimons L, Cooper TB, Halbreich U, Sackeim HA. Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. Biol Psychiatry 1998;44:610-6.
52. Mathe AA, Bergman P, Aperia B, Wetterberg L. Electroconvulsive therapy and plasma prostaglandin E2 metabolite in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:701-7.
53. Fink M, Nemeroff CB. A neuroendocrine view of ECT. Convuls Ther 1989;3:111-20.
54. Fink M. How does convulsive therapy work? Neuropsychopharmacology 1990;3:73-82.
55. Mann JJ, Kapur S. Elucidation of biochemical basis of the antidepressant action of electroconvulsive therapy by human studies. Psychopharmacoll Bull 1994; 30:445-53.
56. Modigh K. Long-term effects of electroconvulsive shock therapy on synthesis turnover and uptake of brain monoamines. Psychopharmacologogy 1976; 49:179-85.
57. Devanand DP, Bowers MB Jr, Hoffman FJ Jr, Sackeim HA. Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin. Biol Psychiatry 1989; 26:408-12.
58. Cooper SJ, Leahey W, Green DF, King DJ. The effect of electroconvulisve therapy on CSF amine metabolites in schizophrenic patients. Br J Psychiatry 1988;152:59-63.
59. Rudorfer ME, Risby E, Osman O, Gold P, Potter W. Hypothalamic pituitary adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapy. Biol Psychiatry 1991;29:253-64.
60. Christie JE, Whalley LJ, Brown NS, Dick H. Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients. Br J Psychiatry 1982;140:268-73.
61. Constain DW, Cowen PJ, Gelder MG, Grahame-Smith DG. Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses. Lancet 1982;2:400-4.
62. Berrios GE, Canagasabey AFB. Depression, eye blink rate, psychomotor retardation and electroconvulsive therapy-enhanced dopamine receptor sensitivity. Convuls Ther 1990;6:224-30.
63. Fochtmann L. A mechanism for the efficacy of ECT in Parkinson's disease. Convuls Ther 1988;4:321-7.
64. Mokhtar AS, Morgan CJ, Bradley DM, Badawy AA. No early effects of electroconvulsive therapy on tryptophan metabolism and disposition in endogenous depression. Biol Psychiatry 1997;42:201-5.
65. Ishihara K, Sasa M. Electroconvulsive therapy is used to treat drug-resistant depressive disorders. Jpn J Pharmacol 1999;80:185-9.
66. Plein H, Berk M. Changes in the platelet intracellular calcium response to serotonin in patients with major depression treated with electroconvulsive therapy: state or trait marker status. Int Clin Psychopharmacol 2000;15:2:93-8.
67. Shapira B, Kindler S, Gropp C, et al. Neuroendocrine evidence for a serotonergic mechanism common to electroconvulsive therapy and imipramine in Antidepressants - Thirty years On. En: Leonard B, Spencer P, eds. Oxford: Oxford University Press; 1990. p. 245-51.
68. Slade AP, Chckley SA. A neuroendocrine study of the mechanism of action of ECT. Br J Psychiatry 1980; 137:217-21.
69. Werstiok ES, Coote M, Griffith L, Shannon H, Steiner M. Effects of electroconvulsive therapy on peripheral adrenoceptors plasma noradrenaline, MHPG and cortisol in depressed patients. Br J Psychiatry 1996; 169:758-65.
70. Kelly CB, Cooper SJ. Plasma noradrenaline response to electroconvulsive therapy in depressive illness. Br J Psychiatry 1997;171:182-6.